Yuyao Li
Shuguang, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Newly Established Anoikis-Associated Genes Predict the Prognosis of Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: April 09, 2025
Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: July 26, 2023
Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Journal: BMC cancer
Published: March 17, 2023
Advances of multi-omics applications in hepatic precancerous lesions and hepatocellular carcinoma: The role of extracellular vesicles.
Journal: Frontiers in molecular biosciences
Published: December 02, 2022
Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy.
Journal: Journal of hepatocellular carcinoma
Published: July 14, 2022
A novel association of pyroptosis-related gene signature with the prognosis of hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: July 05, 2022
Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: April 29, 2022
Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: October 24, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026